The Latest Breaking News from StockNews.com

The summer marks a typically weak time for the stock market. That is why investors love to say “Sell in May and Go Away”. However, it appears that weakness started in April this year with the S&P 500 (SPY) pulling back from recent highs. At this time the focus is…

Amid increasing healthcare spending, breakthroughs in genomics and personalized medicine, and the adoption of new technologies, the pharma industry is booming. So, let’s analyze Eli Lilly (LLY) and Pfizer (PFE) to determine which pharma stock will surge from their first-quarter earnings. Read on to find out.

Tech giant Apple (AAPL) has released its first-quarter earnings, revealing record-high services revenue. However, concerns arise from shortcomings in its wearables segments and delayed entry into the generative AI space. Let's analyze AAPL's recent performance, assess key fundamentals, and decide whether to buy or wait on the stock.

The biotechnology industry is thriving, fueled by solid government support, rising healthcare spending worldwide, gene editing breakthroughs, and rapid AI adoption. Hence, fundamentally solid biotech stocks Shionogi (SGIOY), United Therapeutics (UTHR), and SIGA Technologies (SIGA) could be ideal buys for potential gains. Keep reading….

Despite an impressive first quarter earnings report, shares of Advanced Micro Devices (AMD) are in a downward spiral. Let's delve into the intricacies of AMD's current market dynamics to uncover the underlying reasons behind this unexpected turn of events.

The internet industry's long-term prospects appear bright thanks to digitalization, increased infrastructure investment, and technological advancements such as 5G networks and the Internet of Things. Given the industry’s solid growth prospects, investors could consider adding fundamentally strong internet stocks, ATRenew (RERE), 1stdibs.Com (DIBS), and Despegar.com (DESP), to their watchlist. Read…

The gold market is primed for solid growth this year, owing to its appeal as a safe haven, growing demand for gold ornaments, and consistent purchases by central banks worldwide. Given this backdrop, investors could consider buying quality gold stocks: Kinross Gold Corporation (KGC), Centamin (CELTF), and Centerra Gold (CGAU).…

The pharmaceutical industry is undergoing rapid growth and expansion, driven by rising medical needs, favorable regulatory measures, and the implementation of pharma 4.0. Hence, investors could snatch up quality pharma stocks Bristol-Myers Squibb (BMY), Spero Therapeutics (SPRO), and OptiNose (OPTN) for steady returns during market dips. Read more.

Given the software industry’s remarkable growth trajectory, one might want to add fundamentally top software stocks GoDaddy (GDDY), SS&C Technologies (SSNC), The Sage Group (SGPYY), Yalla Group (YALA), Vimeo (VMEO) to their watchlist this month. So, let’s delve deeper into the fundamentals of these stocks to gauge their potential….

Limited oil supply aggravated by geopolitical tensions and solid energy consumption could push oil prices higher, creating significant tailwinds for the energy sector. Thus, energy stocks Energy Transfer (ET), Koninklijke Vopak (VOPKY), and Forum Energy (FET) could be ideal buys in May. These stocks are rated B (Buy) in our…

Rising costs, regulatory hurdles, and cyberattacks are some of the challenges that the pharmaceutical industry faces. Although the sector looks well-positioned for growth, not all pharma stocks would be able to capitalize on the industry trends. Therefore, investors should look to avoid fundamentally weak pharma stocks: Madrigal Pharmaceuticals (MDGL), Viking…